Risk factors of asymptomatic restenosis in patients with first anterior ST elevation myocardial infarction treated with primary percutaneous coronary intervention

Kardiologia Polska

Volumn 68, Issue 9, 2010, Pages 987-993

  Wita, Krystian ^a   Kinasz, Leszek ^b   Filipecki, Artur ^a   Lelek, Michał ^a   Szczogiel, Jan ^a   Turski, Maciej ^a   Wȩglarz, Przemysław ^a   Elzbieciak, Marek ^a   Staroń, Adam ^a   Trusz Gluza, Maria ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Polsko Amerykanskie Kliniki Serca Sp z oo   (Poland)

Author keywords

Primary percutaneous coronary intervention; Silent restenosis; STEMI

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN; TICLOPIDINE; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT IMPLANTATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HUMAN; IMPLANTATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; RISK FACTOR; SILENT RESTENOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 77958531252     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bassand JP, Hamm CW, Ardissino D et al. Guidelines for diagnosis and treatment of non-ST elevation acute coronary syndromes. The task force for diagnosis and treatment of non-ST elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J, 2007; 28: 1598-1660.
2. Van de Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J, 2008; 29: 2909-2945.
3. Schuhlen H, Kastrati A, Mehilli J et al. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J, 2004; 147: 317-322.
4. Ellis SG, O'Shaughnessy Ch, Steven L. Martin SL et al. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J, 2008; 29: 1625-1634.
5. Hong SN, Ahn Y, Yoon NS et al. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels. Am J Cardiol, 2007; 99: 1051-1054.
6. Ferrante G, Niccoli G, Biasucci LM et al Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med, 2008; 9: 156-165.
7. Pasterkamp G, de Kleijn DP, Borst C. Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications. Cardiovasc Res, 2000; 45: 843.
8. Laarman G, Luijten H, Zeyl L et al. Assessment of Silent restenosis and long-term follow-up. After successful angioplasty in single vessel coronary artery disease: the value of quantitative exercise electrocardiography and quantitative coronary angiography. J Am Coll Cardiol, 1990; 16: 578-585. (Pubitemid 20296119)
9. Assali AR, Moustapha A, Sdringola S et al. Acute coronary syndrome may occur within stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol, 2006; 98: 729-733. (Pubitemid 44301001)
10. Kornowski R, Vaknin-Assa H, Lev E et al. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction. Acute Card Care, 2008; 10: 167-172.
11. Peters S. Comparison of efficacy of low and high dose valsartan in the prevention of in-stent restenosis after implantation of baremetal stents in type B2/C coronary artery lesions. Am J Cardiovasc Drugs, 2008; 8: 88-90.
12. Haraldsdottir S, Gudnason T, Siourdsson AF et al. Diagnostic accuracy of 64 slice multidetector CT for detection of in-stent restenosis in an unselected, consecutive patient population. Eur J Radiol, 2009; 29 [Epub ahead of print].
13. Pache J, Kastrati A, Mehilli J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome. J Am Coll Cardiol, 2003; 16: 1283-1288. (Pubitemid 36438988)
14. Wohrle J, Nusser T, Langenwalder S et al. Carbon-coated stents in patients with acute coronary syndromes. Clin Cardiol, 2009; 32: E1-E6.
15. Boland JL, Corbeij HA, Van der Giessen W et al. Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: the SOPHOS study. Int J Cardiovasc Intervent, 2000;4: 215-225.
16. Giglioli C, Valente S, Margheri M et al. An angiographic evaluation of restenosis rate at six-month follow-up of patients with ST-elevation myocardial infarction submitted to primary percutaneous coronary intervention. Int J Cardiol, 2009: 24: 362-369.
17. Erne P, Schoenenberger AW, Burckhardt D et al. Effects of percutaneous coronary interventions in silent ischaemia after myocardial infarction: the SWISSI III randomized controlled trial. JAMA, 2007; 298: 860-861.
18. Ruygrok P, Webster M, de Valk V et al. Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention. Circulation, 2001; 104: 2289-2294.
19. Cutlip DE, Chhabra AG, Baim DS et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation, 2004; 110: 1226-1230.
20. Mercato N, Boersma E, Wijns W et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent. J Am Coll Cardiol, 2001; 38: 645-652. (Pubitemid 32835730)
21. Lambert ND, Sacrinty MT, Ketch TR et al. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J, 2009; 157: 688-694.
22. De Luca G, Suryaoranata H, Ottervanger JP et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation, 2004; 109: 1223-1225. (Pubitemid 38372780)
23. Gibson CM, Murphy SA, Kirtane AJ et al. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol, 2004; 44: 980-987. (Pubitemid 39165130)
24. Ritman EL, Lerman A. The dynamic vasa vasorum. Cardiovasc Res, 2007; 75: 649-658.
25. Laarmann GJ, Suttorp MJ, Dirksen MT et al. Paclitaxel-eluting versus uncoated stents In primary percutaneous coronary intervention. N Engl J Med, 2006; 355: 1105-1113.
26. Kastrati A, Dibra A, Spaulding C et al. Meta-analysis of randomized trias on drug-eluting stents vs bare-metal stents In patients with acute myocardial infarction. Eur Hart J, 2007; 28: 2706-2713. (Pubitemid 350139205)